Next 10 |
2024-03-27 16:37:05 ET More on NuCana NuCana: Potential Turnaround In 2024 But Risky NuCana GAAP EPS of -£0.14 Seeking Alpha’s Quant Rating on NuCana Historical earnings data for NuCana Financial information for NuCana Read the f...
EDINBURGH, United Kingdom, March 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing one (1) ordinary share, to one (1) ADS representing twenty-fiv...
2024-03-20 17:00:46 ET More on NuCana NuCana: Potential Turnaround In 2024 But Risky Seeking Alpha’s Quant Rating on NuCana Historical earnings data for NuCana Financial information for NuCana Read the full article on Seeking Alpha For ...
Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024 Randomized Phase 2 Study of 171 Second-Line Colorectal Cancer Patients Fully Recrui...
2024-03-14 06:12:00 ET These Are the Top Technical Indicators to Use When Trading Penny Stocks Trading penny stocks offers a unique opportunity for investors to gain significant returns on their investment, despite the generally lower price point of these stocks. However, navigating the...
EDINBURGH, United Kingdom, Feb. 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at TD Cowen’s 44th Annual Health Care Conference. Even...
EDINBURGH, United Kingdom, Feb. 06, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present and host one-on-one meetings at the Oppenheimer 34th Annual Healthcare Life Sciences Conference....
2024-01-03 02:39:07 ET Summary NCNA is a beaten-down stock for numerous reasons, including failure of its prior lead candidate (Acelarin) in two phase 3 trials, as well as a limited cash runway. However, there are good reasons to believe that NCNA's current lead candidate, NUC-337...
2023-11-16 16:43:51 ET More on NuCana Seeking Alpha’s Quant Rating on NuCana Historical earnings data for NuCana Financial information for NuCana For further details see: NuCana GAAP EPS of -£0.13
Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Data Pipeline Continues to Advance with Data Updates Expected for all Programs in 2024 Well Capitalized with Anticipated Cash Runway into 2025 EDINBURGH, United K...
News, Short Squeeze, Breakout and More Instantly...
EDINBURGH, United Kingdom, March 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing one (1) ordinary share, to one (1) ADS representing twenty-fiv...
Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024 Randomized Phase 2 Study of 171 Second-Line Colorectal Cancer Patients Fully Recrui...
2024-03-14 06:12:00 ET These Are the Top Technical Indicators to Use When Trading Penny Stocks Trading penny stocks offers a unique opportunity for investors to gain significant returns on their investment, despite the generally lower price point of these stocks. However, navigating the...